Viking Therapeutics stock, in contrast, might dodge a bullet on this news. And why? As CNBC reports today, the Biden administration is using its last few days in office to add 15 prescription ...

As of 11 a.m. ET, shares of Novo Nordisk (NYSE: NVO) are down 4.2%, and Hims & Hers Health (NYSE: HIMS) stock is getting walloped for a 5.8% loss. In contrast, shares of Viking Therapeutics ...

When Viking said in February that patients on its injectable weight loss drug VK2735 had lost 15% of their body weight after thirteen weeks, the stock jumped more than 120% in a single day.

Viking Holdings stock is cruising higher in its debut. Shares of the luxury cruise operator closed at $26.10 a share on Wednesday, after opening at $26.15, nearly 9% above its initial public ...

Viking Therapeutics, Inc. (VKTX) closed at $42.53 in the latest trading session, marking a -0.84% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.55% for ...

While the focus on Viking increases investment volatility, data from competitors or new licensing deals could significantly affect its stock. William Blair remains confident that Viking offers a ...

It's been a volatile year for Viking Therapeutics stock, though good news on the weight-loss-drug front has the healthcare stock up 260% since the start of January. And Wall Street sees even more ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn’t one of them. The 10 stocks that ...